vs
Side-by-side financial comparison of MID PENN BANCORP INC (MPB) and Vanda Pharmaceuticals Inc. (VNDA). Click either name above to swap in a different company.
MID PENN BANCORP INC is the larger business by last-quarter revenue ($62.0M vs $57.2M, roughly 1.1× Vanda Pharmaceuticals Inc.). MID PENN BANCORP INC runs the higher net margin — 31.4% vs -246.8%, a 278.1% gap on every dollar of revenue. On growth, MID PENN BANCORP INC posted the faster year-over-year revenue change (30.8% vs 7.6%). MID PENN BANCORP INC produced more free cash flow last quarter ($71.8M vs $-29.5M). Over the past eight quarters, MID PENN BANCORP INC's revenue compounded faster (21.1% CAGR vs 9.8%).
Commerce Bancorp was a Cherry Hill, New Jersey–based bank created in 1973. In 2007, it was purchased by Toronto-Dominion Bank, which merged Commerce into TD Banknorth, the latter of which was rebranded to TD Bank.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its key marketed products cover indications including sleep-wake cycle disturbances and schizophrenia, with core operations and primary sales markets concentrated in North America, catering to patient groups with significant unmet medical needs.
MPB vs VNDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.0M | $57.2M |
| Net Profit | $19.4M | $-141.2M |
| Gross Margin | — | — |
| Operating Margin | 43.6% | -70.5% |
| Net Margin | 31.4% | -246.8% |
| Revenue YoY | 30.8% | 7.6% |
| Net Profit YoY | 47.0% | -2774.3% |
| EPS (diluted) | $0.83 | $-2.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.0M | $57.2M | ||
| Q3 25 | $61.8M | $56.3M | ||
| Q2 25 | $54.3M | $52.6M | ||
| Q1 25 | $47.7M | $50.0M | ||
| Q4 24 | $47.4M | $53.2M | ||
| Q3 24 | $45.3M | $47.7M | ||
| Q2 24 | $44.1M | $50.5M | ||
| Q1 24 | $42.3M | $47.5M |
| Q4 25 | $19.4M | $-141.2M | ||
| Q3 25 | $18.3M | $-22.6M | ||
| Q2 25 | $4.8M | $-27.2M | ||
| Q1 25 | $13.7M | $-29.5M | ||
| Q4 24 | $13.2M | $-4.9M | ||
| Q3 24 | $12.3M | $-5.3M | ||
| Q2 24 | $11.8M | $-4.5M | ||
| Q1 24 | $12.1M | $-4.1M |
| Q4 25 | 43.6% | -70.5% | ||
| Q3 25 | 39.3% | -55.6% | ||
| Q2 25 | 7.9% | -73.2% | ||
| Q1 25 | 35.2% | -82.0% | ||
| Q4 24 | 34.1% | -19.3% | ||
| Q3 24 | 32.8% | -23.1% | ||
| Q2 24 | 32.4% | -20.1% | ||
| Q1 24 | 34.8% | -19.5% |
| Q4 25 | 31.4% | -246.8% | ||
| Q3 25 | 29.6% | -40.1% | ||
| Q2 25 | 8.8% | -51.7% | ||
| Q1 25 | 28.8% | -58.9% | ||
| Q4 24 | 27.9% | -9.2% | ||
| Q3 24 | 27.1% | -11.2% | ||
| Q2 24 | 26.7% | -9.0% | ||
| Q1 24 | 28.7% | -8.7% |
| Q4 25 | $0.83 | $-2.40 | ||
| Q3 25 | $0.79 | $-0.38 | ||
| Q2 25 | $0.22 | $-0.46 | ||
| Q1 25 | $0.71 | $-0.50 | ||
| Q4 24 | $0.72 | $-0.09 | ||
| Q3 24 | $0.74 | $-0.09 | ||
| Q2 24 | $0.71 | $-0.08 | ||
| Q1 24 | $0.73 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $84.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $814.1M | $327.2M |
| Total Assets | $6.1B | $488.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $84.9M | ||
| Q3 25 | — | $70.0M | ||
| Q2 25 | — | $81.0M | ||
| Q1 25 | — | $111.8M | ||
| Q4 24 | — | $102.3M | ||
| Q3 24 | — | $100.5M | ||
| Q2 24 | — | $103.0M | ||
| Q1 24 | — | $125.2M |
| Q4 25 | $814.1M | $327.2M | ||
| Q3 25 | $796.3M | $466.0M | ||
| Q2 25 | $775.7M | $486.3M | ||
| Q1 25 | $667.9M | $511.4M | ||
| Q4 24 | $655.0M | $538.5M | ||
| Q3 24 | $573.1M | $541.2M | ||
| Q2 24 | $559.7M | $542.5M | ||
| Q1 24 | $551.0M | $544.0M |
| Q4 25 | $6.1B | $488.9M | ||
| Q3 25 | $6.3B | $601.1M | ||
| Q2 25 | $6.4B | $624.7M | ||
| Q1 25 | $5.5B | $631.9M | ||
| Q4 24 | $5.5B | $656.2M | ||
| Q3 24 | $5.5B | $645.1M | ||
| Q2 24 | $5.4B | $651.4M | ||
| Q1 24 | $5.3B | $652.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $80.0M | $-29.4M |
| Free Cash FlowOCF − Capex | $71.8M | $-29.5M |
| FCF MarginFCF / Revenue | 115.8% | -51.6% |
| Capex IntensityCapex / Revenue | 13.3% | 0.2% |
| Cash ConversionOCF / Net Profit | 4.12× | — |
| TTM Free Cash FlowTrailing 4 quarters | $132.1M | $-110.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.0M | $-29.4M | ||
| Q3 25 | $26.3M | $-31.6M | ||
| Q2 25 | $29.0M | $-15.3M | ||
| Q1 25 | $11.5M | $-33.1M | ||
| Q4 24 | $51.4M | $-1.8M | ||
| Q3 24 | $16.9M | $-14.6M | ||
| Q2 24 | $18.0M | $-6.9M | ||
| Q1 24 | $12.4M | $7.6M |
| Q4 25 | $71.8M | $-29.5M | ||
| Q3 25 | $24.3M | $-31.8M | ||
| Q2 25 | $27.2M | $-15.6M | ||
| Q1 25 | $8.8M | $-33.6M | ||
| Q4 24 | $44.5M | $-2.0M | ||
| Q3 24 | $16.8M | $-14.7M | ||
| Q2 24 | $17.7M | $-7.0M | ||
| Q1 24 | $12.1M | $7.6M |
| Q4 25 | 115.8% | -51.6% | ||
| Q3 25 | 39.4% | -56.5% | ||
| Q2 25 | 50.1% | -29.6% | ||
| Q1 25 | 18.4% | -67.1% | ||
| Q4 24 | 93.8% | -3.8% | ||
| Q3 24 | 37.1% | -30.9% | ||
| Q2 24 | 40.2% | -13.9% | ||
| Q1 24 | 28.5% | 15.9% |
| Q4 25 | 13.3% | 0.2% | ||
| Q3 25 | 3.1% | 0.3% | ||
| Q2 25 | 3.2% | 0.6% | ||
| Q1 25 | 5.7% | 0.9% | ||
| Q4 24 | 14.6% | 0.4% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | 0.7% | 0.2% | ||
| Q1 24 | 0.8% | 0.0% |
| Q4 25 | 4.12× | — | ||
| Q3 25 | 1.44× | — | ||
| Q2 25 | 6.08× | — | ||
| Q1 25 | 0.84× | — | ||
| Q4 24 | 3.88× | — | ||
| Q3 24 | 1.37× | — | ||
| Q2 24 | 1.53× | — | ||
| Q1 24 | 1.02× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MPB
Segment breakdown not available.
VNDA
| Fanapt | $33.2M | 58% |
| Hetlioz | $16.4M | 29% |
| PONVORY | $7.6M | 13% |
